NL180587C - Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten. - Google Patents
Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten.Info
- Publication number
- NL180587C NL180587C NLAANVRAGE7507368,A NL7507368A NL180587C NL 180587 C NL180587 C NL 180587C NL 7507368 A NL7507368 A NL 7507368A NL 180587 C NL180587 C NL 180587C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- diarylbutyl
- benzimidazol
- piperidinyl
- dihydro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- SILNNFMWIMZVEQ-UHFFFAOYSA-N 1,3-dihydrobenzimidazol-2-one Chemical class C1=CC=C2NC(O)=NC2=C1 SILNNFMWIMZVEQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/766—Chemiluminescence; Bioluminescence of gases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/10—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using catalysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/173845—Amine and quaternary ammonium
- Y10T436/175383—Ammonia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/177692—Oxides of nitrogen
- Y10T436/178459—Only nitrogen dioxide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/481,594 US3989707A (en) | 1974-06-21 | 1974-06-21 | Benzimidazolinone derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7507368A NL7507368A (nl) | 1975-12-23 |
NL180587B NL180587B (nl) | 1986-10-16 |
NL180587C true NL180587C (nl) | 1987-03-16 |
Family
ID=23912586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7507368,A NL180587C (nl) | 1974-06-21 | 1975-06-20 | Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten. |
Country Status (25)
Country | Link |
---|---|
US (1) | US3989707A (pl) |
JP (1) | JPS5840553B2 (pl) |
AT (1) | AT345833B (pl) |
AU (1) | AU500910B2 (pl) |
BE (1) | BE830403A (pl) |
CA (1) | CA1053235A (pl) |
CH (1) | CH615173A5 (pl) |
CS (1) | CS190480B2 (pl) |
DE (1) | DE2527261C2 (pl) |
DK (1) | DK141751B (pl) |
ES (1) | ES438714A1 (pl) |
FI (1) | FI59589C (pl) |
FR (1) | FR2275210A1 (pl) |
GB (1) | GB1505173A (pl) |
HU (1) | HU170435B (pl) |
IE (1) | IE41383B1 (pl) |
IL (1) | IL47529A (pl) |
NL (1) | NL180587C (pl) |
NO (1) | NO142400C (pl) |
PH (1) | PH13604A (pl) |
PL (1) | PL98220B1 (pl) |
SE (2) | SE416298B (pl) |
SU (1) | SU585811A3 (pl) |
YU (1) | YU159475A (pl) |
ZA (1) | ZA753968B (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066772A (en) * | 1975-07-21 | 1978-01-03 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
NZ181256A (en) * | 1975-07-21 | 1978-04-28 | Janssen Pharmaceutica Nv | 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives |
US4076821A (en) * | 1976-02-27 | 1978-02-28 | Yoshitomi Pharmaceutical Industries, Ltd. | 4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof |
US4219559A (en) * | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
MA19091A1 (fr) * | 1980-03-10 | 1981-10-01 | Janssen Pharmaceutica Nv | Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine . |
US4777265A (en) * | 1986-03-11 | 1988-10-11 | Basf Aktiengesellschaft | Preparation of acrylates and methacrylates |
DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
AU2388697A (en) | 1996-04-19 | 1997-11-12 | Neurosearch A/S | 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
DE69826278T2 (de) * | 1997-05-30 | 2005-11-10 | Banyu Pharmaceutical Co., Ltd. | 2-oxoimidazol-derivate |
WO2000031061A1 (fr) * | 1998-11-20 | 2000-06-02 | Banyu Pharmaceutical Co., Ltd. | Derives de 2-oxo-imidazole |
EP1196391A1 (en) * | 1999-07-21 | 2002-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
EP1451173A4 (en) * | 2001-11-01 | 2005-10-26 | Icagen Inc | PIPERIDINE |
EP1937670A1 (en) * | 2005-09-30 | 2008-07-02 | Glaxo Group Limited | Benzimidazolones which have activity at m1 receptor |
ES2391107T3 (es) * | 2005-09-30 | 2012-11-21 | Glaxo Group Limited | Compuestos que tienen actividad en el receptor M1 y sus usos en medicina |
KR20130091791A (ko) * | 2005-09-30 | 2013-08-19 | 글락소 그룹 리미티드 | M1 수용체에서 활성을 갖는 화합물 및 그의 의약적 용도 |
GB0605784D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
EP1997381A1 (en) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Use of a compound having a monogalactosyldiacylglycerol synthase inhibitory activity as herbicide or algaecide, herbicide and algaecide compositions |
GB0718415D0 (en) * | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
MX2012001875A (es) * | 2009-08-12 | 2012-07-20 | Janssen Pharmaceutica Nv | Proceso para la preparación de inhibidores de la catepsina s. |
US20240287019A1 (en) * | 2021-06-07 | 2024-08-29 | Kinki University | T-type calcium channel blocker |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE633495A (pl) * | 1962-06-13 | |||
US3161645A (en) * | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
BE659364A (pl) * | 1964-02-05 | |||
US3799932A (en) * | 1970-03-20 | 1974-03-26 | Sumitomo Chemical Co | Gamma-piperidinobutyrophenones |
JPS5511671B2 (pl) * | 1971-08-26 | 1980-03-26 |
-
1974
- 1974-06-21 US US05/481,594 patent/US3989707A/en not_active Expired - Lifetime
-
1975
- 1975-04-25 PH PH17101A patent/PH13604A/en unknown
- 1975-05-14 AU AU81138/75A patent/AU500910B2/en not_active Expired
- 1975-05-15 NO NO751735A patent/NO142400C/no unknown
- 1975-05-19 FI FI751462A patent/FI59589C/fi not_active IP Right Cessation
- 1975-05-21 CA CA227,398A patent/CA1053235A/en not_active Expired
- 1975-05-23 GB GB22512/75A patent/GB1505173A/en not_active Expired
- 1975-05-27 CS CS753693A patent/CS190480B2/cs unknown
- 1975-06-12 FR FR7518434A patent/FR2275210A1/fr active Granted
- 1975-06-18 SE SE7507026A patent/SE416298B/xx unknown
- 1975-06-19 JP JP50073830A patent/JPS5840553B2/ja not_active Expired
- 1975-06-19 HU HUJA735A patent/HU170435B/hu unknown
- 1975-06-19 DE DE2527261A patent/DE2527261C2/de not_active Expired
- 1975-06-19 BE BE157471A patent/BE830403A/xx not_active IP Right Cessation
- 1975-06-19 PL PL1975181386A patent/PL98220B1/pl unknown
- 1975-06-19 ES ES438714A patent/ES438714A1/es not_active Expired
- 1975-06-20 CH CH809875A patent/CH615173A5/de not_active IP Right Cessation
- 1975-06-20 SU SU752148462A patent/SU585811A3/ru active
- 1975-06-20 ZA ZA3968A patent/ZA753968B/xx unknown
- 1975-06-20 IE IE1381/75A patent/IE41383B1/xx unknown
- 1975-06-20 IL IL47529A patent/IL47529A/xx unknown
- 1975-06-20 DK DK281975AA patent/DK141751B/da not_active IP Right Cessation
- 1975-06-20 AT AT476175A patent/AT345833B/de not_active IP Right Cessation
- 1975-06-20 NL NLAANVRAGE7507368,A patent/NL180587C/xx not_active IP Right Cessation
- 1975-07-20 YU YU01594/75A patent/YU159475A/xx unknown
-
1976
- 1976-02-13 SE SE7601636A patent/SE415298B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL180587C (nl) | Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten. | |
NL950007I1 (nl) | 1,2,4-Triazinederivaten, werkwijze voor de bereid ing van deze verbindingen, en deze verbindingen bevattende farmaceutische preparaten. | |
NL7506421A (nl) | Werkwijze voor het bereiden van chromanderivaten en farmaceutische preparaten, bevattende zoda- nige verbindingen. | |
NL7611147A (nl) | Werkwijze voor het bereiden van heterocyclische verbindingen. | |
NL7601069A (nl) | Werkwijze voor het bereiden van preparaten voor orale toediening. | |
NL171356C (nl) | Werkwijze voor het bereiden van 1,3-digesubstitueerde propaan-2-ol derivaten en werkwijze voor het bereiden van farmaceutische preparaten. | |
NL7610208A (nl) | Werkwijze voor het bereiden van zouten van pilocarpine. | |
NL187442C (nl) | Werkwijze voor het bereiden van 1-(benzazolylalkyl)piperidinederivaten en van farmaceutische preparaten, die deze derivaten bevatten. | |
ATE489T1 (de) | Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung. | |
NL190485C (nl) | alfa-Fluormethyl-alfa-aminoalkaanzuurderivaat, farmaceutisch preparaat dat één of meer zodanige verbindingen bevat, alsmede werkwijze voor het bereiden van de verbindingen. | |
NL7510944A (nl) | Werkwijze voor het bereiden van derivaten van indenyl-3-azijnzuur. | |
NL184111C (nl) | Werkwijze voor het bereiden van androstenonen en van farmaceutische preparaten welke deze bevatten. | |
NL7608164A (nl) | Werkwijze voor het bereiden van cefem- en penamverbindingen, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
NL7613050A (nl) | Werkwijze voor het bereiden van tetrahydropyri- dine- en piperidinederivaten. | |
NL7612320A (nl) | Werkwijze voor het bereiden van thiaprostaan- zuurderivaten. | |
NL7509925A (nl) | Werkwijze voor het bereiden van optisch actieve cyclohexaanderivaten. | |
FI890864A0 (fi) | Anvaendning av 1,4-dihydropyridinderivat. | |
NL7605165A (nl) | Werkwijze voor de bereiding van 1-( (5-(4-hy- droxy-2h-1,2-benzothiazin-3-yl)-1,2,4-oxadia- zool-3-yl)methyl)ethanon-s,s-dioxyde. | |
NL7613243A (nl) | Werkwijze voor het bereiden van nieuwe cefalospo- rine derivaten alsmede zodanige verbindingen bevattende farmaceutische preparaten. | |
NL7510287A (nl) | Werkwijze voor het bereiden van basisch gesubsti- tueerde 3-sulfamoylbenzoezuurderivaten. | |
NL186768C (nl) | Werkwijze voor het bereiden van een farmaceutisch of veterinair preparaat, alsmede werkwijze voor het bereiden van daarbij als geneeskrachtige verbinding te gebruiken 3-oxo-5,6-dihydro-1,2,4-oxadiazinen. | |
NL161134B (nl) | Werkwijze ter bereiding van zouten van 3-gesubstitueerde 2,4,6-trijood -5-methoxyacetamido-benzoezuur, alsmede een werkwijze voor het bereiden van een roentgencontrast- middel. | |
NL7701630A (nl) | Werkwijze voor het bereiden van therapeutisch bruikbare piperidinederivaten. | |
NL7603905A (nl) | Werkwijze voor het bereiden van basisch gesubsti- tueerde 5-sulfamoyl-antranilzuurderivaten. | |
NL7613605A (nl) | Werkwijze voor het bereiden van nieuwe chino- linederivaten, alsmede deze verbindingen bevat- tende farmaceutische preparaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
V1 | Lapsed because of non-payment of the annual fee |